Preparing for the Next Pandemic

COVID-19 taught the life science industry a great deal. Now it’s time to capitalise on that knowledge. How can academia, SMEs and the government accelerate new solutions, overcome clinical, manufacturing, regulatory and commercialisation hurdles, and make sure we’re fully armed to tackle the next potential threat?


ROBIN COHEN | Chief Commercial Officer | Emergex Vaccines
DORIS-ANN WILLIAMS MBE | Chief Executive | British In Vitro Diagnostics Association (BIVDA)
SHEULI PORKESS | Vice-President & Founder and Chief Medical Officer | Faculty of Pharmaceutical Medicine & Actaros Consultancy
JANET HEMINGWAY CBE | Professor of Tropical Medicine | Liverpool School of Tropical Medicine
DAME SARAH GILBERT | Saïd Professorship of Vaccinology | Nuffield Department of Medicine, University of Oxford